These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19027488)

  • 1. Aberrant methylation of ADAMTS1 in non-small cell lung cancer.
    Choi JE; Kim DS; Kim EJ; Chae MH; Cha SI; Kim CH; Jheon S; Jung TH; Park JY
    Cancer Genet Cytogenet; 2008 Dec; 187(2):80-4. PubMed ID: 19027488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of A disintegrin and metallopeptidase with thrombospondin motif type 1 by DNA hypermethylation in human gastric cancer.
    Chen J; Zhang C; Xu X; Zhu X; Dai D
    Mol Med Rep; 2015 Aug; 12(2):2487-94. PubMed ID: 25936341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant methylation of FBN2 in human non-small cell lung cancer.
    Chen H; Suzuki M; Nakamura Y; Ohira M; Ando S; Iida T; Nakajima T; Nakagawara A; Kimura H
    Lung Cancer; 2005 Oct; 50(1):43-9. PubMed ID: 15951052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer.
    Chen H; Suzuki M; Nakamura Y; Ohira M; Ando S; Iida T; Nakajima T; Nakagawara A; Kimura H
    Oncol Rep; 2006 May; 15(5):1281-5. PubMed ID: 16596198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer.
    Virmani A; Rathi A; Sugio K; Sathyanarayana UG; Toyooka S; Kischel FC; Tonk V; Padar A; Takahashi T; Roth JA; Euhus DM; Minna JD; Gazdar AF
    Int J Cancer; 2003 Aug; 106(2):198-204. PubMed ID: 12800194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas.
    Heller G; Fong KM; Girard L; Seidl S; End-Pfützenreuter A; Lang G; Gazdar AF; Minna JD; Zielinski CC; Zöchbauer-Müller S
    Oncogene; 2006 Feb; 25(6):959-68. PubMed ID: 16205641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant methylation of Reprimo in lung cancer.
    Suzuki M; Shigematsu H; Takahashi T; Shivapurkar N; Sathyanarayana UG; Iizasa T; Fujisawa T; Gazdar AF
    Lung Cancer; 2005 Mar; 47(3):309-14. PubMed ID: 15713514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic inactivation of laminin-5-encoding genes in lung cancers.
    Sathyanarayana UG; Toyooka S; Padar A; Takahashi T; Brambilla E; Minna JD; Gazdar AF
    Clin Cancer Res; 2003 Jul; 9(7):2665-72. PubMed ID: 12855645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer.
    Zöchbauer-Müller S; Fong KM; Maitra A; Lam S; Geradts J; Ashfaq R; Virmani AK; Milchgrub S; Gazdar AF; Minna JD
    Cancer Res; 2001 May; 61(9):3581-5. PubMed ID: 11325823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.
    Soria JC; Lee HY; Lee JI; Wang L; Issa JP; Kemp BL; Liu DD; Kurie JM; Mao L; Khuri FR
    Clin Cancer Res; 2002 May; 8(5):1178-84. PubMed ID: 12006535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant methylation of the cyclin D2 promoter in primary small cell, nonsmall cell lung and breast cancers.
    Virmani A; Rathi A; Heda S; Sugio K; Lewis C; Tonk V; Takahashi T; Roth JA; Minna JD; Euhus DM; Gazdar AF
    Int J Cancer; 2003 Nov; 107(3):341-5. PubMed ID: 14506731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
    Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF
    Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells.
    Tang X; Wu W; Sun SY; Wistuba II; Hong WK; Mao L
    Mol Cancer Res; 2004 Dec; 2(12):685-91. PubMed ID: 15634757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic down-regulation of death-associated protein kinase in lung cancers.
    Toyooka S; Toyooka KO; Miyajima K; Reddy JL; Toyota M; Sathyanarayana UG; Padar A; Tockman MS; Lam S; Shivapurkar N; Gazdar AF
    Clin Cancer Res; 2003 Aug; 9(8):3034-41. PubMed ID: 12912953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of 17-beta-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer.
    Drzewiecka H; Gałęcki B; Jarmołowska-Jurczyszyn D; Kluk A; Dyszkiewicz W; Jagodziński PP
    Lung Cancer; 2015 Feb; 87(2):107-16. PubMed ID: 25564397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
    Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
    PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC).
    Rocks N; Paulissen G; Quesada Calvo F; Polette M; Gueders M; Munaut C; Foidart JM; Noel A; Birembaut P; Cataldo D
    Br J Cancer; 2006 Mar; 94(5):724-30. PubMed ID: 16495931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of aberrant methylation of prostaglandin E receptor 2 (PTGER2) in nonsmall cell lung cancer: association with prognosis, PTGER2 expression, and epidermal growth factor receptor mutation.
    Tian L; Suzuki M; Nakajima T; Kubo R; Sekine Y; Shibuya K; Hiroshima K; Nakatani Y; Fujisawa T; Yoshino I;
    Cancer; 2008 Sep; 113(6):1396-403. PubMed ID: 18666211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant methylation of CXCL12 in non-small cell lung cancer is associated with an unfavorable prognosis.
    Suzuki M; Mohamed S; Nakajima T; Kubo R; Tian L; Fujiwara T; Suzuki H; Nagato K; Chiyo M; Motohashi S; Yasufuku K; Iyoda A; Yoshida S; Sekine Y; Shibuya K; Hiroshima K; Nakatani Y; Yoshino I; Fujisawa T
    Int J Oncol; 2008 Jul; 33(1):113-9. PubMed ID: 18575756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
    Zhang Y; Miao Y; Yi J; Wang R; Chen L
    Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.